280 related articles for article (PubMed ID: 25263965)
1. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
[TBL] [Abstract][Full Text] [Related]
2. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
3. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
[TBL] [Abstract][Full Text] [Related]
4. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.
Tojo Y; Sekine H; Hirano I; Pan X; Souma T; Tsujita T; Kawaguchi S; Takeda N; Takeda K; Fong GH; Dan T; Ichinose M; Miyata T; Yamamoto M; Suzuki N
Mol Cell Biol; 2015 Aug; 35(15):2658-72. PubMed ID: 26012551
[TBL] [Abstract][Full Text] [Related]
6. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.
Lorenzo FR; Yang C; Ng Tang Fui M; Vankayalapati H; Zhuang Z; Huynh T; Grossmann M; Pacak K; Prchal JT
J Mol Med (Berl); 2013 Apr; 91(4):507-12. PubMed ID: 23090011
[TBL] [Abstract][Full Text] [Related]
7. Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.
Eckardt L; Prange-Barczynska M; Hodson EJ; Fielding JW; Cheng X; Lima JDCC; Kurlekar S; Douglas G; Ratcliffe PJ; Bishop T
Endocr Relat Cancer; 2021 Oct; 28(12):757-772. PubMed ID: 34658364
[TBL] [Abstract][Full Text] [Related]
8. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
[TBL] [Abstract][Full Text] [Related]
10. A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.
Liu Q; Wang Y; Tong D; Liu G; Yuan W; Zhang J; Ye J; Zhang Y; Yuan G; Feng Q; Zhang D; Jiang J
Endocr Pathol; 2017 Mar; 28(1):75-82. PubMed ID: 28116635
[TBL] [Abstract][Full Text] [Related]
11. Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male.
Toyoda H; Hirayama J; Sugimoto Y; Uchida K; Ohishi K; Hirayama M; Komada Y
Pediatrics; 2014 Jun; 133(6):e1787-91. PubMed ID: 24819565
[TBL] [Abstract][Full Text] [Related]
12. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS
J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626
[TBL] [Abstract][Full Text] [Related]
14. PHD2 mutation and congenital erythrocytosis with paraganglioma.
Ladroue C; Carcenac R; Leporrier M; Gad S; Le Hello C; Galateau-Salle F; Feunteun J; Pouysségur J; Richard S; Gardie B
N Engl J Med; 2008 Dec; 359(25):2685-92. PubMed ID: 19092153
[TBL] [Abstract][Full Text] [Related]
15. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
[TBL] [Abstract][Full Text] [Related]
16. Erythrocytosis associated with
Gangat N; Oliveira JL; Porter TR; Hoyer JD; Al-Kali A; Patnaik MM; Pardanani A; Tefferi A
Haematologica; 2022 May; 107(5):1201-1204. PubMed ID: 35142155
[No Abstract] [Full Text] [Related]
17. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
19. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.
Kobayashi H; Liu Q; Binns TC; Urrutia AA; Davidoff O; Kapitsinou PP; Pfaff AS; Olauson H; Wernerson A; Fogo AB; Fong GH; Gross KW; Haase VH
J Clin Invest; 2016 May; 126(5):1926-38. PubMed ID: 27088801
[TBL] [Abstract][Full Text] [Related]
20. Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.
Albiero E; Ruggeri M; Fortuna S; Finotto S; Bernardi M; Madeo D; Rodeghiero F
Haematologica; 2012 Jan; 97(1):123-7. PubMed ID: 21828119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
